Kidney Cancer Clinical Trial

Clinical Trial Finder Kidney Cancer Trials

A Phase II Study of AS1411 in Renal Cell Carcinoma

See Locations Near You

Summary

The aim of this study is to evaluate the efficacy of AS1411 in patients with Metastatic Renal Cell Carcinoma

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histologically or cytologically confirmed renal cell carcinoma containing predominant clear cell histology
Failed or intolerant to 1 or more previous lines of treatments (which must include a Tyrosine Kinase Inhibitor)

Exclusion Criteria:

Collecting duct histology
A history of bleeding disorders or currently taking oral vitamin K antagonise medication
Unstable brain metastases
History of prior or concomitant malignancy (except for curatively treated non-melanoma skin cancer or carcinoma in situ of the cervix, or other cancer for which the patient has been disease free for 3 years)

Study is for people with:

Kidney Cancer

Phase:

Phase 2

Estimated Enrollment:

30

Study ID:

NCT00740441

Recruitment Status:

Unknown status

Sponsor:

Antisoma Research

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

City of Hope
Duarte California, 91010, United States
University of California, Davis Cancer Center
Sacramento California, 95817, United States
University of California San Francisco
San Francisco California, 94143, United States
St Francis Hospital
Beech Grove Indiana, 46107, United States
James Graham Brown Cancer Center, University of Louisville
Louisville Kentucky, 40202, United States
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Boston Massachusetts, 02115, United States
Medical University of South Carolina
Charleston South Carolina, 29403, United States
Load More

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Phase:

Phase 2

Estimated Enrollment:

30

Study ID:

NCT00740441

Recruitment Status:

Unknown status

Sponsor:


Antisoma Research

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider